TENAX THERAPEUTICS, INC. (TENX) Executive Compensation
TENAX THERAPEUTICS, INC. (TENX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TENX
CIK: 34956
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMatthew Urbizo
Audit LocationRaleigh, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-116300 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-13 | — | SCHEDULE 13G/A Filing | 0001178913-26-004757 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-09 | — | SCHEDULE 13G/A Filing | 0001943462-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-08 | 8-K | 0001193125-26-417939 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-16 | 4 | 0001193125-26-394831 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | PRIMARY DOCUMENT | 0001871714-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | 4 | 0001193125-26-392319 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-11 | — | SCHEDULE 13G/A Filing | 0001140361-26-036327 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001193125-26-385910 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | PRIMARY DOCUMENT | 0001940272-26-000020 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-08 | — | SCHEDULE 13G Filing | 0001104659-26-105941 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-08 | — | SCHEDULE 13G/A Filing | 0000315066-26-002289 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | PRIMARY DOCUMENT | 0001940272-26-000019 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-27 | — | SCHEDULE 13G Filing | 0001140361-26-034749 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-27 | — | SCHEDULE 13G Filing | 0001178913-26-004262 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | PRIMARY DOCUMENT | 0001940272-26-000017 | View SEC Doc Filr Page |
| 3 | 2026-08-24 | 2026-08-20 | PRIMARY DOCUMENT | 0001940272-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-18 | — | SCHEDULE 13G Filing | 0001104659-26-098450 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352960 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352650 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000935 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002186 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001213900-26-090068 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001493215-26-000159 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004973 | View SEC Doc Filr Page |